Batın Ilgıt Sezgin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Batın Ilgıt Sezgin has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Ali Menteş
Department of Pediatric Dentistry, Faculty of Dentistry, Marmara University, Istanbul, Turkey
5 shared publications - Gökce Cicek Ildes Sezgin
Istanbul, Turkey
3 shared publications - Alev Eda Okutan
Private Practice, Pediatric Dentistry Clinic, Istanbul, Türkiye
2 shared publications - Alexandre Rezende Vieira
School of Dental Medicine, East Carolina University, Greenville, NC, USA
2 shared publications - Betül Şen Yavuz
Department of Pediatric Dentistry, Faculty of Dentistry, Marmara University, Istanbul, Türkiye
2 shared publications - Eda Haznedaroglu
Department of Pediatric Dentistry, School of Dentistry, Marmara University, Istanbul, Turkey
2 shared publications
Latest Publications
- 30 July 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (8) , 1-14
Clinical and molecular results in 15 Turkish patients with Wiedemann-Steiner syndrome: identification of eight novel KMT2A variants and a case of dual molecular diagnosis in the CSNK2A1
Wiedemann-Steiner syndrome (WSS) is a rare autosomal dominant neurogenetic disorder caused by monallelic variants in KMT2A gene, characterized by neuromotor developmental delay, intellectual disability, microcephaly, seizures, behavioral disorders, dysmorphic facial features, hirsutism, and systemic anomalies. The KMT2A gene encodes a histone lysine methyltransferase crucial for the regulation of gene expression during early developmental stages. In this study, the clinical and molecular findings of 15 Turkish patients with WSS confirmed by whole exome sequencing are reported. Variant segregation was confirmed in all families. The ages of the patients were between 1.5 and 16 years. The majority of patients had neuromotor developmental delay, speech delay, and intellectual disability. The most frequently recognised dysmorphic facial features were thick eyebrows, long eyelashes, synophrys, hypertelorism, and broad nose. Other frequently observed clinical findings included short stature, congenital hypotonia, behavioral problems, genitourinary anomalies, and abnormal gait. Novel findings included focal segmental glomerulosclerosis, cholelithiasis, and sacrococcygeal teratoma. Fifteen different KMT2A variants were detected, including 8 novel (p.Gln3594*, p.Glu1407Argfs*4, p.Ser610Ilefs*9, p.Ser2188Leufs*25, p.Glu970Glnfs*37, p.Ser759Valfs*22, p.Lys1346Serfs*24, and c.11146 + 1_11146 + 6delinsA) variants. Additionally, one patient exhibited a dual molecular diagnosis with a de novo variant in CSNK2A1, associated with Okur-Chung neurodevelopmental syndrome. Conclusion: This study expands the clinical and molecular spectrum of WSS, highlighting novel variants and unique manifestations. It emphasizes the importance of molecular testing in accurate diagnosis and management. By characterizing phenotypic diversity and dual diagnosis, this work contributes valuable insights for advancing clinical care and guiding future research. What is Known: • Wiedemann-Steiner syndrome (WSS) is a rare neurodevelopmental disorder caused by heterozygous KMT2A variants, characterized by developmental delay, intellectual disability, and distinctive facial features. • WSS exhibits marked clinical variability among affected individuals. What is New: • This study presents the largest Turkish WSS cohort to date, expands the phenotypic spectrum with novel findings such as focal segmental glomerulosclerosis, cholelithiasis, and sacrococcygeal teratoma. • This study presents the largest Turkish WSS cohort to date and expands the phenotypic spectrum with novel findings such as focal segmental glomerulosclerosis, cholelithiasis, and sacrococcygeal teratoma, while also identifying eight novel WSS-associated variants, including p.Gln3594*, p.Glu1407Argfs*4, p.Ser610Ilefs*9, p.Ser2188Leufs*25, p.Glu970Glnfs*37, p.Ser759Valfs*22, p.Lys1346Serfs*24, and c.11146+1_11146+6delinsA.
- 30 July 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (8) , 1-14
Clinical and molecular results in 15 Turkish patients with Wiedemann-Steiner syndrome: identification of eight novel KMT2A variants and a case of dual molecular diagnosis in the CSNK2A1
Wiedemann-Steiner syndrome (WSS) is a rare autosomal dominant neurogenetic disorder caused by monallelic variants in KMT2A gene, characterized by neuromotor developmental delay, intellectual disability, microcephaly, seizures, behavioral disorders, dysmorphic facial features, hirsutism, and systemic anomalies. The KMT2A gene encodes a histone lysine methyltransferase crucial for the regulation of gene expression during early developmental stages. In this study, the clinical and molecular findings of 15 Turkish patients with WSS confirmed by whole exome sequencing are reported. Variant segregation was confirmed in all families. The ages of the patients were between 1.5 and 16 years. The majority of patients had neuromotor developmental delay, speech delay, and intellectual disability. The most frequently recognised dysmorphic facial features were thick eyebrows, long eyelashes, synophrys, hypertelorism, and broad nose. Other frequently observed clinical findings included short stature, congenital hypotonia, behavioral problems, genitourinary anomalies, and abnormal gait. Novel findings included focal segmental glomerulosclerosis, cholelithiasis, and sacrococcygeal teratoma. Fifteen different KMT2A variants were detected, including 8 novel (p.Gln3594*, p.Glu1407Argfs*4, p.Ser610Ilefs*9, p.Ser2188Leufs*25, p.Glu970Glnfs*37, p.Ser759Valfs*22, p.Lys1346Serfs*24, and c.11146 + 1_11146 + 6delinsA) variants. Additionally, one patient exhibited a dual molecular diagnosis with a de novo variant in CSNK2A1, associated with Okur-Chung neurodevelopmental syndrome. Conclusion: This study expands the clinical and molecular spectrum of WSS, highlighting novel variants and unique manifestations. It emphasizes the importance of molecular testing in accurate diagnosis and management. By characterizing phenotypic diversity and dual diagnosis, this work contributes valuable insights for advancing clinical care and guiding future research. What is Known: • Wiedemann-Steiner syndrome (WSS) is a rare neurodevelopmental disorder caused by heterozygous KMT2A variants, characterized by developmental delay, intellectual disability, and distinctive facial features. • WSS exhibits marked clinical variability among affected individuals. What is New: • This study presents the largest Turkish WSS cohort to date, expands the phenotypic spectrum with novel findings such as focal segmental glomerulosclerosis, cholelithiasis, and sacrococcygeal teratoma. • This study presents the largest Turkish WSS cohort to date and expands the phenotypic spectrum with novel findings such as focal segmental glomerulosclerosis, cholelithiasis, and sacrococcygeal teratoma, while also identifying eight novel WSS-associated variants, including p.Gln3594*, p.Glu1407Argfs*4, p.Ser610Ilefs*9, p.Ser2188Leufs*25, p.Glu970Glnfs*37, p.Ser759Valfs*22, p.Lys1346Serfs*24, and c.11146+1_11146+6delinsA.
- Open Access
- 12 June 2024
- Published by Springer Nature in BMC Oral Health
- Vol. 24 (1) , 1-10
Hyaluronic acid as a pulpotomy material in primary molars: an up to 30 months retrospective study
Background: The aim of this retrospective study was to determine the long-term clinical and radiographic success of our previous randomized clinical trial and to compare the success of hyaluronic acid, with the widely used formocresol and ferric sulphate agents. Methods: This retrospective study is the extension of the 1-year survey of our randomized clinical trial that had compared the effectiveness of a hyaluronic acid pulpotomy over formocresol and ferric sulphate pulpotomies and included clinical and radiographic evaluations with a follow-up period of over 24 months for 44 children who applied to our clinic between May 2019 and September 2019. Long-term clinical and radiographic data were obtained from the periodic files of our department, wherein each tooth’s file was examined to identify any clinical and radiographic findings. Descriptive statistics and Pearson’s chi-square tests were used to evaluate the data. Statistical significance was considered as p < 0.05. Results: The clinical and radiographic success rates of the hyaluronic acid, formocresol, and ferric sulphate groups were not statistically different at > 24 months. None of the teeth in the hyaluronic acid group showed any clinical findings at > 24 months. Conclusions: Hyaluronic acid pulpotomies exhibited comparable success rates to formocresol and ferric sulphate materials spanning over 24 months examinations. Because of convenient accessibility and applicability of hyaluronic acid, it may be recommended as a promising alternative medicament for pulpotomy treatments of primary molars. However, further long-term follow-up human studies are needed to better understand the effect of hyaluronic acid on the dental pulp of human primary molars.
- 12 June 2024
- Published by Springer Nature in BMC Oral Health
- Vol. 24 (1) , 1-10
Open AccessHyaluronic acid as a pulpotomy material in primary molars: an up to 30 months retrospective study
Background: The aim of this retrospective study was to determine the long-term clinical and radiographic success of our previous randomized clinical trial and to compare the success of hyaluronic acid, with the widely used formocresol and ferric sulphate agents. Methods: This retrospective study is the extension of the 1-year survey of our randomized clinical trial that had compared the effectiveness of a hyaluronic acid pulpotomy over formocresol and ferric sulphate pulpotomies and included clinical and radiographic evaluations with a follow-up period of over 24 months for 44 children who applied to our clinic between May 2019 and September 2019. Long-term clinical and radiographic data were obtained from the periodic files of our department, wherein each tooth’s file was examined to identify any clinical and radiographic findings. Descriptive statistics and Pearson’s chi-square tests were used to evaluate the data. Statistical significance was considered as p < 0.05. Results: The clinical and radiographic success rates of the hyaluronic acid, formocresol, and ferric sulphate groups were not statistically different at > 24 months. None of the teeth in the hyaluronic acid group showed any clinical findings at > 24 months. Conclusions: Hyaluronic acid pulpotomies exhibited comparable success rates to formocresol and ferric sulphate materials spanning over 24 months examinations. Because of convenient accessibility and applicability of hyaluronic acid, it may be recommended as a promising alternative medicament for pulpotomy treatments of primary molars. However, further long-term follow-up human studies are needed to better understand the effect of hyaluronic acid on the dental pulp of human primary molars.
- Open Access
- 16 February 2024
- Published by Springer Nature in Research Square
Hyaluronic acid as a pulpotomy material in primary molars: an up to 30 months retrospective study
Objectives The aim of this retrospective study was to determine the long-term clinical and radiographic success of our previous randomized clinical trial (RCT) and to compare the success of hyaluronic acid (HA), with the widely used formocresol (FC) and ferric sulphate (FS) agents. Materials and methods This retrospective study is the extension of the 1-year survey of our RCT that had compared the effectiveness of a HA pulpotomy over FC and FS pulpotomies and included clinical and radiographic evaluations with a follow-up period of over 24 months for 44 children who applied to our clinic between May 2019 and September 2019. Long-term clinical and radiographic data were obtained from the periodic files of our department, wherein each tooth's file was examined to identify any clinical and radiographic findings. Descriptive statistics and Pearson chi-square tests were used to evaluate the data. Statistical significance was considered as p24 months (p=0.163 and p=0.977, respectively). None of the teeth in the HA group showed any clinical findings at >24 months. Conclusions HA pulpotomies exhibited comparable success rates to FC and FS materials spanning over 24 months examinations. Further long-term follow-up human studies are needed to better understand the effect of HA on the dental pulp of human primary molars. Clinical relevance Because of convenient accessibility and applicability of HA, it may be recommended as a promising alternative medicament for pulpotomy treatments of primary molars.
- 16 February 2024
- Published by Springer Nature in Research Square
Open AccessHyaluronic acid as a pulpotomy material in primary molars: an up to 30 months retrospective study
Objectives The aim of this retrospective study was to determine the long-term clinical and radiographic success of our previous randomized clinical trial (RCT) and to compare the success of hyaluronic acid (HA), with the widely used formocresol (FC) and ferric sulphate (FS) agents. Materials and methods This retrospective study is the extension of the 1-year survey of our RCT that had compared the effectiveness of a HA pulpotomy over FC and FS pulpotomies and included clinical and radiographic evaluations with a follow-up period of over 24 months for 44 children who applied to our clinic between May 2019 and September 2019. Long-term clinical and radiographic data were obtained from the periodic files of our department, wherein each tooth's file was examined to identify any clinical and radiographic findings. Descriptive statistics and Pearson chi-square tests were used to evaluate the data. Statistical significance was considered as p24 months (p=0.163 and p=0.977, respectively). None of the teeth in the HA group showed any clinical findings at >24 months. Conclusions HA pulpotomies exhibited comparable success rates to FC and FS materials spanning over 24 months examinations. Further long-term follow-up human studies are needed to better understand the effect of HA on the dental pulp of human primary molars. Clinical relevance Because of convenient accessibility and applicability of HA, it may be recommended as a promising alternative medicament for pulpotomy treatments of primary molars.
- Open Access
- 13 February 2024
- Published by Springer Nature in BMC Oral Health
- Vol. 24 (1) , 1-7
Management options and long-term follow-ups for permanent double incisors: six to eleven-year case reports
Background: Double teeth are dental anomalies that can lead to aesthetic and orthodontic problems. Case presentation: This report discusses two cases involving the multidisciplinary management of permanent maxillary left lateral incisors fused with a supernumerary tooth in two girls aged 9 and 10. Following intraoral and radiographic examinations, one was diagnosed with fusion, and the other was diagnosed with concrescence. The crown of the fused incisor was separated using a burs and extracted intraorally. The concrescent incisor was separated along its length using a laser and intentionally replanted extraorally. After a 6-year follow-up, no pathological signs were observed in the fused incisor. However, after an 11-year follow-up, external resorption was observed in the concrescent incisor. Conclusions: Both incisors remained asymptomatic throughout the observation period. This case report highlights two different and effective methods employed to preserve the natural function, form, and aesthetics of double incisors.
- 13 February 2024
- Published by Springer Nature in BMC Oral Health
- Vol. 24 (1) , 1-7
Open AccessManagement options and long-term follow-ups for permanent double incisors: six to eleven-year case reports
Background: Double teeth are dental anomalies that can lead to aesthetic and orthodontic problems. Case presentation: This report discusses two cases involving the multidisciplinary management of permanent maxillary left lateral incisors fused with a supernumerary tooth in two girls aged 9 and 10. Following intraoral and radiographic examinations, one was diagnosed with fusion, and the other was diagnosed with concrescence. The crown of the fused incisor was separated using a burs and extracted intraorally. The concrescent incisor was separated along its length using a laser and intentionally replanted extraorally. After a 6-year follow-up, no pathological signs were observed in the fused incisor. However, after an 11-year follow-up, external resorption was observed in the concrescent incisor. Conclusions: Both incisors remained asymptomatic throughout the observation period. This case report highlights two different and effective methods employed to preserve the natural function, form, and aesthetics of double incisors.
- 26 April 2023
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 124 (6) , 101485
Retrospective evaluation of traction time for impacted dilacerated maxillary central incisors in mixed dentition
- 26 April 2023
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 124 (6) , 101485
Retrospective evaluation of traction time for impacted dilacerated maxillary central incisors in mixed dentition
- 9 November 2021
- Published by Medical Journals Sweden AB in Acta Odontologica Scandinavica
- Vol. 80 (4) , 273-280
A randomized clinical trial of hyaluronic acid gel pulpotomy in primary molars with 1 year follow-up
This randomized clinical study aimed to evaluate the success of hyaluronic acid (HA) as a pulpotomy medicament of human primary molars and to compare it with formocresol (FC) and ferric sulphate (F...
- 9 November 2021
- Published by Medical Journals Sweden AB in Acta Odontologica Scandinavica
- Vol. 80 (4) , 273-280
A randomized clinical trial of hyaluronic acid gel pulpotomy in primary molars with 1 year follow-up
This randomized clinical study aimed to evaluate the success of hyaluronic acid (HA) as a pulpotomy medicament of human primary molars and to compare it with formocresol (FC) and ferric sulphate (F...
- 1 December 2018
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 50, 216-222
Two-fold excess of fluoride in the drinking water has no obvious health effects other than dental fluorosis
- 1 December 2018
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 50, 216-222
Two-fold excess of fluoride in the drinking water has no obvious health effects other than dental fluorosis